Inspire Medical Systems, Inc. to Report Third Quarter 2021 Financial Results on November 2, 2021

Rhea-AI Summary

Inspire Medical Systems (NYSE: INSP) announced it will release its third quarter 2021 financial results on November 2, 2021, after market close. A conference call to discuss these results and recent business developments will follow at 5:00 p.m. ET. Inspire focuses on innovative solutions for obstructive sleep apnea, with its Inspire therapy being the first FDA-approved neurostimulation treatment for moderate to severe cases. For more information, visit www.inspiresleep.com.

News Market Reaction – INSP

+0.15%

+0.15% Session move

In the trading session that priced this news, INSP gained 0.15%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MINNEAPOLIS, Oct. 05, 2021 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, today announced that it will release financial results for the third quarter 2021 after the close of trading on Tuesday, November 2. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

Tuesday, November 2nd @ 5:00 p.m. Eastern Time:
Domestic:	800-344-0786
International:	209-905-5969
Conference ID:	8449129
Webcast:	https://edge.media-server.com/mmc/p/utdpmguo

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact:
Bob Yedid
LifeSci Advisors
inspire@lifesciadvisors.com
646-597-6989

FAQ

When will Inspire Medical Systems release its Q3 2021 financial results?

Inspire Medical Systems will release its Q3 2021 financial results on November 2, 2021, after market close.

What is the time for Inspire Medical Systems' Q3 2021 conference call?

The conference call for Inspire Medical Systems' Q3 2021 financial results will begin at 5:00 p.m. Eastern Time on November 2, 2021.

What is Inspire's focus in the medical technology sector?

Inspire Medical Systems focuses on developing and commercializing innovative and minimally invasive solutions for patients with obstructive sleep apnea.

What is Inspire therapy?

Inspire therapy is the first and only FDA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.